Shenzhen Salubris Pharmaceuticals Co Ltd (002294) — Cash Flow Quality Index
Shenzhen Salubris Pharmaceuticals Co Ltd (002294) has a Cash Flow Quality Index of 1.86x as of September 2025. Operating cash flow of CN¥400.70 Million exceeds net income of CN¥215.63 Million, indicating high earnings quality where cash backs reported profits. Explore Shenzhen Salubris Pharmaceuticals Co Ltd (002294) cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shenzhen Salubris Pharmaceuticals Co Ltd Cash Flow Quality Index (2006–2024)
Historical Cash Flow Quality Index for Shenzhen Salubris Pharmaceuticals Co Ltd across 19 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check total reinvestment intensity of Shenzhen Salubris Pharmaceuticals Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Shenzhen Salubris Pharmaceuticals Co Ltd (2006–2024)
Year-by-year earnings quality comparison for Shenzhen Salubris Pharmaceuticals Co Ltd. For live market cap and the full company financial profile, see market value of Shenzhen Salubris Pharmaceuticals Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.96x | CN¥1.19 Billion | CN¥605.16 Million | ▲ +30.7% |
| 2023 | 1.50x | CN¥869.79 Million | CN¥580.07 Million | ▼ -2.0% |
| 2022 | 1.53x | CN¥970.80 Million | CN¥634.22 Million | ▼ -31.8% |
| 2021 | 2.24x | CN¥1.18 Billion | CN¥528.32 Million | ▼ -91.8% |
| 2020 | 27.41x | CN¥1.37 Billion | CN¥50.13 Million | ▲ +1140.6% |
| 2019 | 2.21x | CN¥1.51 Billion | CN¥681.84 Million | ▲ +139.7% |
| 2018 | 0.92x | CN¥1.34 Billion | CN¥1.45 Billion | ▼ -9.1% |
| 2017 | 1.01x | CN¥1.46 Billion | CN¥1.44 Billion | ▼ -1.7% |
| 2016 | 1.03x | CN¥1.43 Billion | CN¥1.39 Billion | ▲ +24.1% |
| 2015 | 0.83x | CN¥1.06 Billion | CN¥1.27 Billion | ▼ -11.7% |
| 2014 | 0.94x | CN¥982.25 Million | CN¥1.04 Billion | ▲ +17.3% |
| 2013 | 0.80x | CN¥668.52 Million | CN¥833.26 Million | ▼ -2.2% |
| 2012 | 0.82x | CN¥521.21 Million | CN¥635.55 Million | ▲ +22.1% |
| 2011 | 0.67x | CN¥272.32 Million | CN¥405.45 Million | ▲ +27.9% |
| 2010 | 0.53x | CN¥186.65 Million | CN¥355.51 Million | ▼ -15.7% |
| 2009 | 0.62x | CN¥134.28 Million | CN¥215.68 Million | ▼ -6.5% |
| 2008 | 0.67x | CN¥77.89 Million | CN¥116.94 Million | ▼ -7.7% |
| 2007 | 0.72x | CN¥52.75 Million | CN¥73.14 Million | ▲ +105.7% |
| 2006 | 0.35x | CN¥12.00 Million | CN¥34.24 Million | — |